Document details
The activity of raltitrexed (Tomudex®) in malignant pleural mesothelioma : an EORTC phase II study (08992)
Author(s) :
Legrand, Catherine
Description :
We investigated the activity and toxicity of raltitrexed (Tomudex®) as a single agent treatment in patients with Malignant Pleural Mesothelioma (MPM) in a multicentre phase II European Organization for Research and Treatment of Cancer (EORTC) study. This study enrolled chemonaı̈ve patients with hist...
Language(s) :
English
Subject(s) :
Publisher(s) :
(United Kingdom) Kidlington Pergamon
Contributor(s) :
UCL - EUEN/STAT - Institut de statistique
Source(s) :
Publication Date(s) :
2003-01-01